Notice to Stakeholders – Clarification of Requirements Under the Food and Drug Regulations When Conducting Clinical Research With Cannabis

Health Canada is issuing this notice to clinical trial sponsors to clarify key obligations under the Food and Drug Regulations (FDR) for various types of cannabis-based clinical research.

Data and Resources

Additional Info

Field Value
Last Updated April 17, 2026, 21:39 (UTC)
Created April 17, 2026, 21:39 (UTC)
criticality_level []
geographic_scope []
open_canada_collection publication
open_canada_date_published 2021-02-05 00:00:00
open_canada_keywords {"fr": ["avis aux intervenants", "clarification des exigences", "Règlement sur les aliments et drogues", "essai clinique", "recherche clinique", "cannabis"], "en": ["notice to stakeholders", "clarification of requirements", "Food and Drug Regulations", "clinical trial", "clinical research", "cannabis"]}
open_canada_subject ["health_and_safety"]
sensitivity_level unrestricted
title_fr Avis aux intervenants – Clarification des exigences prévues par le Règlement sur les aliments et drogues lors de la conduite de recherches cliniques sur le cannabis
update_frequency as_needed